BACKGROUND/AIMS: Hypothalamic hamartomas are the most common identifiable cause of central precocious puberty (CPP). Hamartoma characteristics proposed to be associated with CPP include specific anatomic features and expression of molecules such as gonadotropin-releasing hormone (GnRH), transforming growth factor alpha (TGFalpha), and GRM1A, which encodes the type 1 metabotropic glutamate receptor alpha isoform. We sought to determine whether hamartomas that cause CPP could be distinguished by anatomic features, expression of these molecules, or expression of KISS1, whose products signal through the receptor GPR54 to stimulate GnRH release. METHODS: Clinical records and radiologic images were reviewed for 18 patients who underwent hamartoma resection for intractable seizures; 7 had precocious puberty. Resected tissue was examined for expression of GnRH, GnRH receptor (GnRHR), TGFalpha, KISS1, GPR54, and GRM1A. RESULTS: Hypothalamic hamartomas associated with CPP were more likely to contact the infundibulum or tuber cinereum and were larger than hamartomas not associated with CPP. GnRH, TGFalpha, and GnRHR were expressed by all hamartomas studied. Expression of KISS1, GPR54, and GRM1A did not differ significantly between hamartomas associated and not associated with CPP. CONCLUSION: Anatomic features rather than expression patterns of candidate molecules distinguish hypothalamic hamartomas that are associated with CPP from those that are not. Copyright 2010 S. Karger AG, Basel.
BACKGROUND/AIMS: Hypothalamic hamartomas are the most common identifiable cause of central precocious puberty (CPP). Hamartoma characteristics proposed to be associated with CPP include specific anatomic features and expression of molecules such as gonadotropin-releasing hormone (GnRH), transforming growth factor alpha (TGFalpha), and GRM1A, which encodes the type 1 metabotropic glutamate receptor alpha isoform. We sought to determine whether hamartomas that cause CPP could be distinguished by anatomic features, expression of these molecules, or expression of KISS1, whose products signal through the receptor GPR54 to stimulate GnRH release. METHODS: Clinical records and radiologic images were reviewed for 18 patients who underwent hamartoma resection for intractable seizures; 7 had precocious puberty. Resected tissue was examined for expression of GnRH, GnRH receptor (GnRHR), TGFalpha, KISS1, GPR54, and GRM1A. RESULTS:Hypothalamic hamartomas associated with CPP were more likely to contact the infundibulum or tuber cinereum and were larger than hamartomas not associated with CPP. GnRH, TGFalpha, and GnRHR were expressed by all hamartomas studied. Expression of KISS1, GPR54, and GRM1A did not differ significantly between hamartomas associated and not associated with CPP. CONCLUSION: Anatomic features rather than expression patterns of candidate molecules distinguish hypothalamic hamartomas that are associated with CPP from those that are not. Copyright 2010 S. Karger AG, Basel.
Authors: Stephen W Coons; Harold L Rekate; Erin C Prenger; Norman Wang; Cornelia Drees; Yu-tze Ng; Steven S Chung; John F Kerrigan Journal: J Neuropathol Exp Neurol Date: 2007-02 Impact factor: 3.685
Authors: Jie Wu; Lin Xu; Do Young Kim; Jong M Rho; Paul A St John; Lih-Fen Lue; Stephen Coons; Kevin Ellsworth; Lee Nowak; Eric Johnson; Harold Rekate; John F Kerrigan Journal: Ann Neurol Date: 2005-09 Impact factor: 10.422
Authors: Yu-tze Ng; Harold L Rekate; Erin C Prenger; Steve S Chung; Iman Feiz-Erfan; Norman C Wang; Maggie R Varland; John F Kerrigan Journal: Epilepsia Date: 2006-07 Impact factor: 5.864
Authors: Milena Gurgel Teles; Suzy D C Bianco; Vinicius Nahime Brito; Ericka B Trarbach; Wendy Kuohung; Shuyun Xu; Stephanie B Seminara; Berenice B Mendonca; Ursula B Kaiser; Ana Claudia Latronico Journal: N Engl J Med Date: 2008-02-14 Impact factor: 91.245
Authors: Pierre Bourdillon; S Ferrand-Sorbet; C Apra; M Chipaux; E Raffo; S Rosenberg; C Bulteau; N Dorison; O Bekaert; V Dinkelacker; C Le Guérinel; M Fohlen; G Dorfmüller Journal: Neurosurg Rev Date: 2020-04-21 Impact factor: 3.042
Authors: Nathan T Cohen; J Helen Cross; Alexis Arzimanoglou; Samuel F Berkovic; John F Kerrigan; Ilene Penn Miller; Erica Webster; Lisa Soeby; Arthur Cukiert; Dale K Hesdorffer; Barbara L Kroner; Clifford B Saper; Andreas Schulze-Bonhage; William D Gaillard Journal: Neurology Date: 2021-10-04 Impact factor: 9.910